Saber qué tipo de extintor usar en cada situación puede marcar la diferencia entre apagar un incendio a tiempo o provocar una catástrofe. Aunque todos cumplen la misma función —sofocar el fuego—, no todos los extintores sirven para lo mismo. Cada uno est&aacut …
Tipos de extintores y sus usos: guía completa para saber cuál necesitas Read More »
Todos lo hemos vivido: estás viendo una película triste, las lágrimas comienzan a rodar por tus mejillas… y de repente, ¡empieza a gotearte la nariz! Este curioso fenómeno, conocido popularmente como “moquear al llorar”, tiene una explicació …
Por qué moqueamos al llorar: la ciencia detrás de las lágrimas y la nariz que gotea Read More »
La resina natural es una sustancia viscosa producida por diversas especies de árboles —principalmente coníferas como el pino o el abeto— como mecanismo de defensa ante heridas o infecciones. Este material orgánico, de textura pegajosa y aroma característico, h …
Resina natural: Propiedades, usos y beneficios del “oro vegetal” Read More »
While the FDA continues to put out guidance documents and approve drugs, some companies are already reporting delays in dealings with the agency, while insiders warn of falling morale and a negative perception from the rest of the biopharma world.
FDA Struggles to Keep Lights On Amid Shutdown as Biopharmas Begin To See Delays Read More »
Mergers and acquisitions are not just for Big Pharma. A new report from Leerink Partners takes a stab at identifying the small- to mid-cap pharmas best prepared to bolster their pipelines with a buyout.
The medtech firm is using Nvidia’s technology in its Monarch robotic platform for urology.
J&J partners with Nvidia on AI for kidney stone procedures Read More »
The healthcare giant beat Wall Street expectations in the third quarter and raised its 2025 earnings guidance, albeit modestly.
UnitedHealth maps path back to Wall Street’s good graces Read More »
CEO Bob White and Chief Strategy Officer Gabriela Kaynor discussed the medtech company’s quality and technology priorities after a year of change.
Olympus execs talk about import alert, GI robot and AI Read More »
Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.
Health systems are racing to adopt AI. But can they prove its value? Read More »
Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.
Medtronic links renal denervation to 3-year blood pressure reduction Read More »
